Pretomanid (PA-824)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pretomanid (PA-824), covering 2017-04-04 to 2017-04-04. Get the full timeline:
Most recent: Clinical Trial Update: PA-824-CL-007: Phase IIa Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis [Phase 2]